U.S. Enteral Feeding Formulas Market Size & Outlook
Related Markets
U.S. enteral feeding formulas market highlights
- The U.S. enteral feeding formulas market generated a revenue of USD 2,057.0 million in 2024 and is expected to reach USD 2,883.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.7% from 2025 to 2030.
- In terms of segment, standard formula was the largest revenue generating product in 2024.
- Disease Specific Formulas is the most lucrative product segment registering the fastest growth during the forecast period.
Enteral feeding formulas market data book summary
| Market revenue in 2024 | USD 2,057.0 million |
| Market revenue in 2030 | USD 2,883.3 million |
| Growth rate | 5.7% (CAGR from 2025 to 2030) |
| Largest segment | Standard formula |
| Fastest growing segment | Disease Specific Formulas |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Standard Formula, Disease Specific Formulas |
| Key market players worldwide | Abbott Laboratories, Danone SA, Fresenius Kabi AG, Nestle SA, Victus, Primus Pharmaceuticals, Inc., Meiji Holdings Co Ltd, Mead Johnson & Company, LLC |
Other key industry trends
- In terms of revenue, U.S. accounted for 26.9% of the global enteral feeding formulas market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. enteral feeding formulas market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 360.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Enteral Feeding Formulas Market Scope
Enteral Feeding Formulas Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fresenius Kabi AG | View profile | 10001+ | Bad Homburg, Hessen, Germany, Europe | https://www.fresenius-kabi.com |
| Primus Pharmaceuticals | View profile | 51-100 | Scottsdale, Arizona, United States, North America | http://primusrx.com |
| Victus | View profile | 1-10 | Miami, Florida, United States, North America | https://www.victus.com/ |
| Reckitt Benckiser Group PLC | View profile | 40000 | 103-105 Bath Road, Slough, Berkshire, United Kingdom, SL1 3UH | https://www.reckitt.com |
| Meiji Holdings Co Ltd | View profile | 24532 | 4-16, Kyobashi 2-chome, Chuo-ku, Tokyo, Japan, 104-0031 | http://www.meiji.com |
| Danone SA | View profile | 88843 | 17, Boulevard Haussmann, Paris, France, 75009 | https://www.danone.com |
| Nestle SA | View profile | 270000 | Avenue Nestle 55, Vevey, Switzerland, CH-1800 | https://www.nestle.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
U.S. enteral feeding formulas market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to enteral feeding formulas market will help companies and investors design strategic landscapes.
Standard formula was the largest segment with a revenue share of 63.73% in 2024. Horizon Databook has segmented the U.S. enteral feeding formulas market based on standard formula, disease specific formulas covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. enteral feeding formulas market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. enteral feeding formulas market databook
-
Our clientele includes a mix of enteral feeding formulas market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. enteral feeding formulas market , including forecasts for subscribers. This country databook contains high-level insights into U.S. enteral feeding formulas market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. enteral feeding formulas market size, by product, 2018-2030 (US$M)
U.S. Enteral Feeding Formulas Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
